Detalhe da pesquisa
1.
Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia.
Br J Haematol
; 200(6): 717-721, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442510
2.
Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma.
Ann Hematol
; 102(6): 1421-1431, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041299
3.
Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms.
Ann Hematol
; 102(4): 819-827, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36862167
4.
Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies.
Br J Haematol
; 197(6): 691-696, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226358
5.
Humoral response to mRNA-based COVID-19 vaccine in patients with de novo and pre-existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination.
Br J Haematol
; 199(4): 627-630, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096497
6.
Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin's Lymphoma: A Single-Center Cohort Study.
Viruses
; 16(3)2024 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543695
7.
Booster effect of a third mRNA-based COVID-19 vaccine dose in patients with myeloid malignancies.
Cancer Med
; 12(16): 16881-16888, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37409608